PDS Biotechnology (PDSB) Tops Q3 EPS by 10c

PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c